We're #hiring a new Scientist III/IV, Medicinal Chemistry in San Diego, California. Apply today or share this post with your network.
Qpex Biopharma
Biotechnology Research
San Diego, California 1,476 followers
Focusing on Resistance in Antibiotic Development
About us
Qpex Biopharma, Inc. a Shionogi Group Company, is a resistance-focused infectious disease company on a mission to make both a dramatic and sustainable improvement in patient care. Leveraging a multi-faceted approach and a deep understanding of drug resistance mechanisms, we are creating novel products and development. strategies that overcome multi-drug resistance. We are advancing a robust portfolio of treatments that will bring innovation to antibiotic development and deliver the right treatments to the right patients in the right settings. During the previous decade, our team brought 4 antibiotic products to regulatory approvals, with an extensive record of working with public- private partnerships, including partnerships with the Biomedical Advanced Research and Development Authority (BARDA) that led to the first approved antimicrobial drug product under that program in 2017. San Diego-based Qpex was launched in 2018 with investments from New Enterprise Associates, Adams Street Partners, LYZZ Capital, Hatteras Venture Partners and Stanford University Daper Fund. In July 2023, Qpex was acquired by Shionogi, Inc and is now a Shionogi Group Company.
- Website
-
http://www.qpexbio.com
External link for Qpex Biopharma
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- San Diego, California
- Type
- Public Company
- Founded
- 2018
- Specialties
- Drug Discovery, Anti-Infective Therapies, Antibiotics, Drug Development, Drug Resistance, Microbiology, and Boron Chemistry
Locations
-
Primary
Get directions
11440 W Bernardo Ct
Suite 300
San Diego, California 92127, US
Employees at Qpex Biopharma
Updates
-
We're #hiring a new Scientist I/II, Medicinal Chemistry in San Diego, California. Apply today or share this post with your network.
-
We're #hiring a new Associate Director/Director of Anti-Infective Pharmacology in San Diego, California. Apply today or share this post with your network.
-
We're #hiring a new Purchasing Specialist in San Diego, California. Apply today or share this post with your network.
-
In becoming part of Shionogi, a global company, Qpex Biopharma is expanding its operations in infectious diseases and drug discovery in San Diego. https://lnkd.in/gpfcwQ77
-
Qpex Biopharma reposted this
We are hiring a Senior Director of Regulatory Affairs with a focus on vaccine and/or bacterial products. If this aligns with your expertise, I would love to connect. #hiring #seniordirector #vaccine #bacterialproducts
-
The Qpex Biopharma team combines it’s quarter of a century of senior leaders working together that includes innovation that led to the first FDA-approved beta-lactamse inhibitor from a new boronate chemical class. We are proud and humbled to be part of an organization with a rich history of innovation and commercialization of important products.
Michael Dudley, PharmD, President and CEO of Qpex Biopharma, a Shionogi Group Company, discusses how our recent announcement at #BIO2024 of a new drug discovery laboratory is expanding the existing R&D footprint of Qpex Biopharma in San Diego. Watch here:
-
We are open for business…. and hiring!
Announced today at #BIO2024: In response to the urgent global need for additional antimicrobial research and development, we’re establishing our first discovery laboratory in the U.S. This new R&D facility for Qpex Biopharma, a Shionogi Group Company, will increase capabilities in infectious disease. Read more about the announcement here: https://lnkd.in/enniDGcq
-
-
“It is vital that we invest in the development of new medicines to help mitigate future threats, including pandemics and antimicrobial resistance. In addition, we must lower barriers and create incentives to support the training and development of the next generation of scientists and researchers, particularly in antimicrobial resistance, or AMR, where the workforce has been declining for decades,” said Phyllis Arthur, Executive Vice President & Head, Healthcare Policy and Programs, Biotechnology Innovation Organization (BIO), who moderated the panel. “The expertise of Shionogi and Qpex scientists in this facility in the U.S. will enhance drug discovery and development efforts and help make medicines available that can support future public health, economic and national security concerns.” Thank you Phyllis and Dr. Keller… we agree!
#ICYMI: We announced we established our first discovery laboratory in the U.S. at #BIO2024. John Keller, PhD, Senior Executive Officer and SVP, R&D Supervisory Unit, Shionogi & Co. Ltd., shares how this new R&D facility for Qpex Biopharma, a Shionogi Group Company, will build on our longstanding legacy of innovation in infectious disease. Learn more: https://lnkd.in/enniDGcq
-